From Melrose Health's debut in the longevity health space to the recall of Uncle Frog's Mushroom Gummies in Australia, and India's ongoing debate on its nutraceutical regulatory framework, here are the most-read stories on NutraIngredients-Asia...
Kobayashi Pharmaceutical is appointing a new CEO, while the outgoing chief will return half of his six months remuneration in the aftermath of the firm’s red yeast rice scandal.
Manufacturers of Foods with Function Claims (FFC) are legally bound to four newly added requirements from September 1 – the latest move in regulating Japan’s functional foods industry since Kobayashi Pharmaceutical’s red yeast rice scandal broke out.
Japan’s Consumer Affairs Agency (CAA) has made it mandatory for companies making Food with Function Claims (FFC) in the supplement format, such as tablets and capsules, to follow the Good Manufacturing Practices (GMP). They are also required to report...
Researchers have found low rate of kidney injury, muscle symptoms and liver dysfunction attributed to red yeast rice consumption, following a meta-analyses spanning a decade.
Kobayashi Pharmaceutical reported an “extraordinary loss” of nearly US$25m (JPY$3.86bn) in its Q1 results due to the recall of its contaminated red yeast rice products, raw materials, and compensation of medical expenses.
From Japan's Kobayashi Pharmaceutical's red yeast rice supplement scandal to Unilever's hydration brand Liquid I.V. making its way into more markets, including China and Australia, here are the most-read stories on NutraIngredients-Asia...
More than 110 health hazards involving 18 Foods with Function Claims (FFC) products were declared by FFC businesses over the past two weeks, Japan’s Consumer Affairs Agency (CAA) said.
Japan’s Consumer Affairs Agency (CAA), which oversees the Foods with Function Claims (FFC) sector, is asking all businesses to declare any health hazards linked to their products in the wake of Kobayashi Pharmaceutical’s red yeast rice saga.
Red yeast rice extract production would need to fulfill three key elements of testing to ensure product safety, industry experts highlighted amid an ongoing crisis involving products made using Japan’s Kobayashi Pharmaceutical's red yeast rice raw...
Japan’s Kobayashi Pharmaceutical is halting the production of all its red yeast rice raw material and supplements containing the raw material, following consumer complaints of kidney disease. The company is also recalling all of its products that contain...